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Hypertrophic Cardiomyopathy (HCM) has been related to many different mutations
in more than 20 different, mostly sarcomeric proteins. While development of the
HCM-phenotype is thought to be triggered by the different mutations, a common
mechanism remains elusive. Studying missense-mutations in the ventricular beta-myosin
heavy chain (β-MyHC, MYH7) we hypothesized that significant contractile heterogeneity
exists among individual cardiomyocytes of HCM-patients that results from cell-to-cell
variation in relative expression of mutated vs. wildtype β-MyHC. To test this hypothesis,
we measured force-calcium-relationships of cardiomyocytes isolated from myocardium
of heterozygous HCM-patients with either β-MyHC-mutation Arg723Gly or Arg200Val,
and from healthy controls. From the myocardial samples of the HCM-patients
we also obtained cryo-sections, and laser-microdissected single cardiomyocytes for
quantification of mutated vs. wildtype MYH7-mRNA using a single cell RT-qPCR and
restriction digest approach. We characterized gene transcription by visualizing active
transcription sites by fluorescence in situ hybridization of intronic and exonic sequences
of MYH7-pre-mRNA. For both mutations, cardiomyocytes showed large cell-to-cell
variation in Ca++-sensitivity. Interestingly, some cardiomyocytes were essentially
indistinguishable from controls what might indicate that they had no mutant β-MyHC
while others had highly reduced Ca++-sensitivity suggesting substantial fractions of
mutant β-MyHC. Single-cell MYH7-mRNA-quantification in cardiomyocytes of the same
patients revealed high cell-to-cell variability of mutated vs. wildtype mRNA, ranging
from essentially pure mutant to essentially pure wildtype MYH7-mRNA. We found 27%
of nuclei without active transcription sites which is inconsistent with continuous gene
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transcription but suggests burst-like transcription of MYH7. Model simulations indicated
that burst-like, stochastic on/off-switching of MYH7 transcription, which is independent
for mutant and wildtype alleles, could generate the observed cell-to-cell variation in
the fraction of mutant vs. wildtype MYH7-mRNA, a similar variation in β-MyHC-protein,
and highly heterogeneous Ca++-sensitivity of individual cardiomyocytes. In the long run,
such contractile imbalance in the myocardium may well induce progressive structural
distortions like cellular and myofibrillar disarray and interstitial fibrosis, as they are typically
observed in HCM.
Keywords: hypertrophic cardiomyopathy, human cardiomyocytes, single-cell allelic imbalance, ventricular myosin
heavy chain, myosin mutations, burst-like transcription
INTRODUCTION
Hypertrophic Cardiomyopathy (HCM) is the most frequent
inherited cardiac disease with a prevalence of about 1:500 (Maron
et al., 1995). It is characterized by asymmetric hypertrophy of
the left ventricle in the absence of other causes for hypertrophy
(Maron and Maron, 2013). HCM can vary from essentially
asymptomatic to highly malignant up to end-stage heart failure,
or cause life threatening arrhythmias with sudden cardiac death
particularly in young adults (Richardson et al., 1996). Two
different presentations of HCM can be found in patients,
the obstructive form (HOCM), where patients suffer from
an obstruction of the left ventricular outflow tract, and the
non-obstructive form (HNCM). Cardiomyocyte disarray with
interstitial fibrosis and hypertrophy are hallmarks of HCM
(Varnava et al., 2000). The degree of myocardial disarray
correlates with risk factors for sudden cardiac death (Varnava
et al., 2000), and it was suggested that myocyte disarray directly
results from functional changes induced by the HCM related
mutations at the sarcomeric level (Ashrafian et al., 2011).
In most familial HCM cases, heterozygous mutations in
sarcomeric proteins such as the β-myosin heavy chain (β-
MyHC), cardiac myosin-binding protein C (cMyBPC), cardiac
troponin-T (cTnT), and cardiac troponin-I (cTnI) have been
identified. Very few mutations were found in non-sarcomeric
proteins (Ho et al., 2015a). About one third of the patients are
heterozygous for mutations in MYH7 (encoding β-MyHC) and
MYBPC3 (encoding cMyBPC) (Richard et al., 2003; Ho et al.,
2015a).
It was proposed that the different HCM mutations lead to
the HCM phenotype by enhancing contractility, and increasing
calcium-sensitivity and ATPase activity of the cardiomyocytes
(Ashrafian et al., 2011), while the opposite changes were thought
to result in dilated cardiomyopathy (DCM) (Robinson et al.,
2002; Hoskins et al., 2010; Davis et al., 2016). In studies on
expressed human β-myosin with HCM-mutations also evidence
for a hypercontractile state was found (Sommese et al., 2013;
Bloemink et al., 2014). As mechanism for the postulated
hypercontractility in HCM it was recently suggested that the
mutations increase the availability of myosin heads for force
production by altering the putative folded back state of the
myosin heads (Kawana et al., 2017; Nag et al., 2017). Results
from our group and others, however, are inconsistent with a
generally enhanced contractility in HCM. Instead, contractility
and calcium sensitivity can be enhanced or decreased in HCM
(Venkatraman et al., 2003; Kirschner et al., 2005; Mirza et al.,
2005; van Dijk et al., 2012; Kraft et al., 2013). Hence, the
pathomechanism of HCM development is still unclear and a
common trigger of HCM has yet to be identified.
In our work, we focused on HCM related mutations in
β-MyHC which in humans is also expressed in slow twitch
skeletal muscle fibers of e.g., M. soleus. For several missense
mutations in the β-MyHC, we found reduced Ca++-sensitivity
(Kirschner et al., 2005; Kraft et al., 2013). To our surprise,
however, some muscle fibers showed a Ca++-sensitivity quite
similar to fibers of control individuals while other fibers of
the same patient had highly reduced Ca++-sensitivity, yielding
a spectrum of different Ca++-sensitivities from normal to
highly reduced within the same tissue sample (Kirschner
et al., 2005). Based on these findings we hypothesized that
significant functional heterogeneity also exists among individual
cardiomyocytes of HCM-patients, and that this may result from
cell-to-cell variation in expression of mutated β-MyHC. Within
the myocardial cellular network, such unequal force generation
among adjacent cardiomyocytes will result in distortions of
cardiomyocytes and non-myocyte cells. Some of these will be
overstretched or distorted by cardiomyocytes that overcontract.
Such distortions could not only initiate cardiomyocyte and
myofibrillar disarray but could also trigger stretch-induced
signaling, e.g., TGF-β-signaling (Teekakirikul et al., 2010), that
results in development of interstitial fibrosis and hypertrophy.
Thus, cell-to-cell functional variance may initiate hallmarks of
the HCM phenotype (Brenner et al., 2014).
In the present work, we tested our hypothesis by studying
contractile properties of individual cardiomyocytes of HCM-
patients’ myocardium and expression of mutated MYH7-
mRNA at the single cardiomyocyte level in the same tissue
samples. We found significant functional heterogeneity in
Ca++-sensitivity among individual cardiomyocytes of affected
HCM patients, including cardiomyocytes with Ca++-sensitivity
essentially indistinguishable from control cells. This may result
from cell-to-cell variation in the fractions of expressed mutant
and wildtype protein, including cardiomyocytes expressing low
or almost no fraction of mutant protein. To directly test for
cell-to-cell variability in expression of the mutant vs. wildtype
alleles, we quantified mutant vs. wildtype transcript in individual
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cardiomyocytes isolated from the same tissue samples. We found
substantial cell-to-cell variability ranging from essentially pure
wildtype to essentially pure mutantMYH7-mRNA expression in
the very same patients. Data from counting active transcription
sites and model calculations suggest that stochastic, burst-like
transcription ofMYH7, which is independent for the mutant and
the wildtype allele, could generate the large cell-to-cell variation
in mutant vs. wildtype MYH7-mRNA and β-MyHC-protein,
resulting in substantial functional heterogeneity.
MATERIALS AND METHODS
For detailed methods, additional figures, and references see
Supplementary Material.
Patients and Controls
This study was carried out in accordance with the
recommendations of the Ethics Committee of Hannover
Medical School with written informed consent from all subjects.
All subjects gave written informed consent in accordance
with the Declaration of Helsinki (WMA, 1997). The study
on anonymized human tissue was approved by the Ethics
Committee of Hannover Medical School (No. 2276-2014).
Samples of left ventricular free wall and interventricular septum
with β-MyHC-mutation p.R723G were from myocardium of
two male HCM patients who received a heart transplant (patient
II-5, family 26 and patient III-1, family 157) (Enjuto et al., 2000).
A sample of the interventricular septum was obtained during
myectomy from a severely affected female with Hypertrophic
Obstructive Cardiomyopathy (HOCM) with the β-MyHC-
mutation p.A200V. Control heart tissue from the left-ventricular
free wall and interventricular septum was from non-transplanted
donor hearts (n = 5). Cardiac tissue was flash frozen in liquid
nitrogen immediately after excision.
Single Cardiomyocyte Function
Cardiomyocytes were mechanically isolated and contraction
parameters were measured at different Ca++-concentrations
(pCa-values) from relaxing (pCa 9.0) to saturating Ca++-
concentration (pCa 4.63) as previously described (Kraft et al.,
2013), and (for mutation A200V) as described in Supplementary
Material (Figure S1). To adjust PKA-dependent phosphorylation
which has been shown previously to be higher in donor cardiac
tissue compared to HCM-patient’s cardiac tissue (Kraft et al.,
2013), all cardiomyocytes of donors and patients were incubated
with protein kinase A (PKA) prior to functional assessment. It
has been shown that PKA treatment of donor cardiomyocytes
induced only a small shift of the force-pCa-relation to higher
calcium-concentrations, while for cardiomyocytes from patients
with heart failure or HCM-patients the shift was significant (van
der Velden et al., 2003; Kraft et al., 2013).
Relative Quantification of Mutant vs.
Wildtype MYH7-mRNA in Individual
Cardiomyocytes
Cryosections (thickness 5µm) from frozen left-ventricular
cardiac tissue were generated and sections of individual
cardiomyocytes were isolated by laser capture microdissection
after anti-cadherin staining of desmosomes (Figure S2).
Individual cardiomyocytes were identified by the bright-field
image clearly showing the striation pattern and were dissected
when overlaying the bright-field image and the fluorescent
image of intercalated discs labeled by an anti-cadherin-antibody.
The cells were marked, laser-dissected, and catapulted from the
tissue section into nuclease free water in the lid of a PCR-tube
and lysed. Quantitative single cell RT-PCR was performed
(for conditions and primers see Table S1 and Supplementary
Material). The lysates were subjected to reverse transcription
reaction mix and incubated on a custom-made micro-mixer
for 10min to improve uniform distribution of the low amount
of mRNA molecules (Boon et al., 2011) and subsequently split
into duplicates that were analyzed in parallel. The micro-mixer
was also used to optimize successive cDNA synthesis (Boon
et al., 2011). For relative quantification of the MYH7 alleles
in single cardiomyocytes, nested PCR was applied, followed
by a reconditioning PCR to avoid heteroduplex-formation
(Thompson et al., 2002). For allele specific restriction digest,
R723G- or A200V-PCR-products were treated with MboI or
Hpy4CHI, respectively, yielding an allele-specific band pattern.
Quantification of mutant vs. wildtype MYH7-mRNA occurred
densitometrically after testing for linearity using standard
plasmids of wildtype, R723G, or A200V sequence of the PCR-
amplicons as described (Tripathi et al., 2011) (Supplementary
Material, Figure S3).
Multi-Aliquot Control
A section of a sample from the left ventricular free wall of
R723G-myocardium was lysed, diluted serially and subjected
to quantitative single cell RT-PCR. The diluted lysate with a
normalized IOD comparable to that of single cardiomyocytes was
then divided into several aliquots for parallel quantification as
described (Supplementary Material).
MYH7-mRNA Copy Number in Individual
Cardiomyocytes
Standard-RNA was generated by in vitro transcription using
MYH7-cDNA. Single cardiomyocytes were microdissected and
total MYH7-mRNA was determined by absolute quantification
using real-time PCR and serial dilutions of the standard-RNA.
Quantification of Mutated β-Myosin Protein
With Mutation A200V in Tissue Samples
As described (Becker et al., 2007) (Supplementary Material;
Figure S4), sarcomere-bound myosin was extracted from
A200V-myocardium and digested by trypsin. Specific mutant
and wildtype peptides were quantified by HPLC and mass
spectrometry using corresponding synthetic stable-isotope-
labeled internal standard peptides.
Visualizing Active Transcription Sites
Active transcription sites were visualized by fluorescence in situ
hybridization (FISH) using sets of 48 20-mer oligonucleotides
(Stellaris R©-probes; LGC Biosearch Technologies, Petaluma, CA,
USA). One set was designed to hybridize with intronic sequences
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of MYH7-pre-mRNA and each oligonucleotide was labeled
with one Cy5-like fluorophore (Quasar 670, LGC Biosearch
Technologies). The other set was designed to hybridize with
exonic sequences of MYH7-mRNA and labeled with a Cy3-
like fluorophore (Quasar 570; LGC Biosearch Technologies).
Both probe sets were custom made (Stellaris R© Probe Designer).
Following hybridization, active transcription sites were taken
as bright spots inside nuclei of cardiomyocytes showing
both fluorescence signals. Further details are described in
Supplementary Material.
Modeling of Independent, Burst-Like
Transcription of Mutant, and Wildtype
MYH7-Alleles
Model calculations were based on the concept of stochastic,
burst-like transcription (Raj et al., 2006) including independent
transcription and translation of mutant and wildtype MYH7-
alleles to account for our experimentally observed mutant
vs. wildtype transcript levels and function of individual
cardiomyocytes from the heterozygous R723G-patient II-5.
Modeling included the stochastic opening and closing of the
transcription sites, synthesis of pre-mRNA, splicing to mRNA,
degradation of mRNA, and synthesis and degradation of protein,
each for mutant and wildtype, respectively. The only adjustable
parameters were the rate constants for activation/inactivation of
transcription of the two alleles and the splicing rate constant;
all other rate constants were taken from the literature. From
the measured fraction of mutated β-MyHC-protein in R723G-
patient myocardium and the mean pCa50-values of controls
and R723G-patient cardiomyocytes we could also simulate a
distribution of pCa50-values. For details onmodeling constraints,
additional results and references see Supplementary Material.
Statistical Analysis
Data are presented as mean ± SD or ± 1.96 SD (range in which
95% of data points are expected; see Supplementary Material).
To assure normal distribution (Shapiro-Wilk test) of normalized
data, logit transformation was performed for statistics (Ashton,
W. D., 1972). Student’s t-test was used to determine significance
levels. Equality of variances was examined by F-test. For p < 0.05
significance was assumed.
RESULTS
Large Cell-to-Cell Functional
Heterogeneity Among Individual
Cardiomyocytes From HCM Patients
Force-pCa Relations
Cell-to-cell functional heterogeneity among individual
cardiomyocytes of HCM patients was investigated by recording
force-pCa relations of cardiomyocytes isolated from myocardial
samples with β-MyHC-mutations R723G (Enjuto et al., 2000)
and A200V, respectively, and of healthy controls for comparison
(Figure 1). Force data of each cardiomyocyte were normalized to
the maximum force at saturating Ca++-concentration (pCa 4.5).
Interestingly, force-pCa relations of some cardiomyocytes with
mutation R723G were similar to that of donor cells, while for
others a clear shift to higher Ca++-concentrations was observed
(Figure 1A). The mean shift to reduced Ca++sensitivity with
mutation R723G (Figure S5A) was similar to the change we
had previously found in fibers of M. soleus muscle and in
myocardium of this and other patients with mutation R723G
(Kirschner et al., 2005; Kraft et al., 2013). For cardiomyocytes
with mutation A200V we found a similar pattern with some
force-pCa relations comparable to donor cells and others
with markedly reduced Ca++-sensitivity (Figure 1B). On
average, the force-pCa curve for A200V was slightly shifted
to higher Ca++-concentrations, however, due to the larger
cell-to-cell variability the shift is not statistically significant
(Figure S5B).
For both mutations, the individual force-pCa relations reveal
a larger cell-to-cell variability in the position of the force-pCa
relation along the abscissa, i.e., a larger variability in Ca++-
sensitivity than in control cardiomyocytes (Figures 1A,B). This
is particularly prominent for mutation A200V for which force-
pCa relations vary from the range of the control myocytes
up to positions shifted by about 0.25 pCa units to the right
(red solid lines in Figure 1B). Thus, for both mutations some
cardiomyocytes have a Ca++-sensitivity indistinguishable from
that of control cells while other cells have a substantially
lower Ca++-sensitivity. This is further illustrated by the pCa50-
values of the individual cardiomyocytes obtained from fitting
the Hill equation to the force data of the individual cells. In
Figures 1C,D the pCa50-values of the individual cardiomyocytes
are shown together with the related mean value and the range
in which 95% of data points are expected (mean ± 1.96 SD).
Overall, the pCa50-values of individual R723G and A200V
cardiomyocytes are significantly lower than those of the related
control cells, respectively, and the variances of the pCa50-values
are larger than those for controls. For the A200V cells, the
variance is significantly larger than for controls (p = 0.02;
F-test).
Forces at Partial Activation
Functional consequences of heterogeneities in the force-pCa
relations of individual cardiomyocytes are illustrated when
the forces generated by individual R723G- and control-
cardiomyocytes are compared at partial activation level (pCa
5.55–5.6; boxed areas in Figures 1A,B). The pCa-values 5.5–5.6
represent physiological intracellular Ca++-concentrations in a
twitch (Fabiato, 1981).
For both mutations, the mean relative forces at pCa 5.55–5.6
are significantly lower compared to controls (pR723G < 0.001,
pA200V = 0.025; t-test). For cardiomyocytes of both patients,
variances of forces at partial activation are significantly higher
than that of respective controls (R723G p = 0.003; A200V
p = 0.002; F-test). In fact, at pCa 5.55–5.6 forces generated by
the “weakest” and “strongest” HCM cardiomyocytes were 10-
fold (R723G) or even 20-fold (A200V) different (boxed areas
in Figures 1A,B). In contrast, at the same partial activation,
forces of weakest and strongest control cardiomyocytes differed
at most 1.5-fold (Figures 1A,B). Since normalized forces are
restricted to values between 0 and 1, statistical analysis was
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FIGURE 1 | Force generation by individual cardiomyocytes. Forces of individual left ventricular cardiomyocytes at different calcium-concentrations
(force-pCa-relations), normalized to maximum force, with Hill-functions fitted to data points. (A) β-MyHC-mutation R723G (n = 22) vs. controls (n = 8) and (B)
β-MyHC-mutation A200V (n = 19) vs. controls (n = 17). Mutated cardiomyocytes, red symbols and red solid lines; controls, blue symbols and blue dashed lines.
Different symbols represent different individual cells. The mean force-pCa-relationships are shown in Supplementary Material, Figure S5. (C) pCa50 from individually
fitted Hill-equations for R723G-cardiomyocytes and (D) for A200V-cardiomyocytes vs. controls. Dash-dot lines represent mean pCa50-values (cf. Table 1); dashed
lines delineate range in which 95% of all data points (mean ± 1.96 SD) are expected. pCa50-values of all groups show normal distribution (Shapiro-Wilk test). SD of
pCa50-values of mutated cardiomyocytes larger than that of controls (for A200V-cardiomyocytes statistically significant, p = 0.02, F-test).
done after logit transformation (Ashton, W. D., 1972). For
details see Supplementary Material. The variance of the control
cardiomyocytes reflects experimental error, while the much
larger functional variance among individual cardiomyocytes of
both HCM patients very likely results from an additional, large
intrinsic cell-to-cell heterogeneity of their calcium-sensitivity.
This large intrinsic heterogeneity among individual
cardiomyocytes of HCM patients, where some cells were
very similar to controls and others had very much reduced
Ca++-sensitivity, raised the question whether this reflects
variation from small to rather high fractions of mutated vs.
wildtype protein in these cardiomyocytes, respectively.
Highly Heterogeneous Fraction of Mutant
MYH7-mRNA From Cell-to-Cell
Since protein quantification of mutant vs. wildtype β-MyHCwith
missense mutations in individual cardiomyocytes is beyond the
sensitivity of our mass-spectrometry approach (Becker et al.,
2007; Tripathi et al., 2011), we quantified relative expression of
mutant and wildtypeMYH7-alleles in individual cardiomyocytes
at the mRNA level. We expect this to reflect expression at the
protein level, since in our previous work on several β-MyHC-
mutations including several patients with mutation R723G we
always found a nearly 1:1 relation between fraction of mutant
protein and mutant mRNA at the tissue level (Figure S7B)
(Tripathi et al., 2011; Montag et al., 2017). Such a 1:1 relation
between MYH7-mRNA and β-MyHC-protein was also found
here and previously for mutation A200V (see below and
Supplementary Material, Figure S7).
As the myocardial tissue samples had been flash-frozen
immediately after surgery, we could not enzymatically isolate
intact individual cardiomyocytes to determine the fraction
of mutant MYH7-mRNA. Instead, individual cardiomyocytes
were isolated from cardiac tissue sections by laser capture
microdissection (Figure S2). Quantification of each cell was
performed in duplicates. A specific micro-mixing method was
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TABLE 1 | Average pCa50 values of cardiomyocytes from controls and from HCM
patients with β-MyHC mutation R723G and A200V, respectively.
pCa50
R723G Controls
5.38 ± 0.05*** 5.53 ± 0.04
n = 22 n = 8
A200V Controls
5.49 ± 0.09* 5.54 ± 0.05
n = 19 n = 17
***p < 0.001; *p = 0.044; n indicates number of cardiomyocytes.
used to optimize cDNA synthesis (Boon et al., 2011). To quantify
the relative abundance of mutant vs. wildtype MYH7-mRNA in
cryosections of individual cardiomyocytes, we adapted the RT-
PCR/restriction digest approach that we had previously used for
quantification ofMYH7-mRNA in tissue samples (Tripathi et al.,
2011).
Three representative restriction analyses of individual A200V-
cardiomyocytes in Figure 2A show that the fraction of mutant
β-cardiac mRNA varies among individual cardiomyocytes from
quite low mutant (cell 1) to almost pure mutant MYH7-mRNA
(cell 3). Figure 2B schematically shows the fragments generated
by the A200V-specific restriction digest. Note, the highly similar
band pattern of the two aliquots of each individual cardiomyocyte
indicates that the large cell-to-cell variability in the abundance
of mutant MYH7-mRNA is not due to experimental error. For a
similar sample gel with R723G-cardiomyocytes see Figure S6 and
previous work for the other patient (Kraft et al., 2016).
Analysis of in total 35 individual R723G-cardiomyocytes
showed that the fraction of mutant MYH7-mRNA varies
from essentially pure mutant to almost pure wildtype MYH7-
mRNA (Figure 2C). This was confirmed for another patient
with the same mutation from another family (Figure S6). To
obtain an estimate for the experimental error in our mRNA
quantification procedure, we generated a “tissue averaged”
cDNA sample that could be divided into multiple aliquots
for parallel analysis following the same procedure as for
the single cardiomyocytes. A whole cryosection of R723G-
tissue was lysed and cDNA was synthesized. This cDNA
sample was diluted and then divided into aliquots such
that each aliquot contained a similar amount of cDNA as
we obtained from individual microdissected cardiomyocytes
(for details see Supplementary Material). Thus, these aliquots
yielded band intensities of the restriction digest that were
similar to those observed with microdissected individual
cardiomyocytes. The fractions of R723G-MYH7-mRNA in
each of the 13 aliquots ranged only between 0.5 and 0.85
(Figure 2D).
Since the fraction of mutant MYH7-mRNA (Fmut_mRNA) is
restricted to the range between 0 and 1, for statistical analysis
Fmut_mRNA was transformed into logits = ln((Fmut_mRNA)/(1-
Fmut_mRNA)). For the 35 microdissected cardiomyocytes,
Fmut_mRNA is the average of the fraction observed in the two
aliquots. Data of both groups, the 35 individual microdissected
R723G-cardiomyocytes and the 13 control samples, showed
normal distribution after logit transformation (Shapiro-Wilk
test). Importantly, the variance in the 13 aliquots of the
large cDNA sample, representing the experimental error,
is significantly smaller than the variance in the fraction of
R723G-MYH7-mRNA among the 35 individual microdissected
cardiomyocytes (Figures 2C,D; p < 0.0001, F-test). In contrast,
the mean fraction of mutated MYH7-mRNA of the aliquots
with 0.69 was comparable to the mean of the individual
cardiomyocytes with 0.70.
Cell-to-cell variance in the fraction of mutant A200V-
MYH7-mRNA is shown in Figure 2E. Isolation of individual
cardiomyocytes and quantitative single cell RT-PCR were
performed as described for R723G, with primers and
endonuclease adapted for A200V. Quantitative analysis of
21 microdissected cardiomyocytes again revealed a much
larger cell-to-cell variation in the fraction of mutant mRNA
(Figure 2E) than seen in the 13-aliquot control. Together,
R723G- and A200V-data reveal a large variability among
individual cardiomyocytes in the expression of the mutated allele
relative to the wildtype allele, i.e., a large cell-to-cell variance of
mutant transcript levels in the myocardium of the HCM patients.
The range of variability for mutant A200V is somewhat smaller
than for mutant R723G (Figure 2C). We did not see very high
fractions of mutated A200V-mRNA which could be due to the
fact that the mean fraction of mutated mRNA in A200V cells and
tissue is lower than for R723G (dash-dot lines in Figures 2C,E,
Figure S7).
Analysis of the average fraction of mutant mRNA in all
analyzed cardiomyocytes together yielded a fraction of 0.70 for
the R723G-patient (dashed-dot-line in Figure 2C, Figure S7A).
This is very similar to the value determined earlier in whole tissue
samples of several patients with R723G at the mRNA and protein
level (four M. soleus and one other cardiac sample) and reflects
the allelic imbalance at the tissue level described previously
(Tripathi et al., 2011) (Figure S7). The higher abundance of
mutantMYH7-mRNA compared to wildtypeMYH7-mRNAmay
be the result of higher stability (longer life-time) of the mutant
MYH7-mRNA (Tripathi et al., 2011).
The average fraction of A200V-mRNA of all analyzed
cardiomyocytes was 0.53 (Figure 2E, Figure S7A), which is very
close to themean value determined in three whole cryosections of
A200V-myocardium of 0.47± 0.05 (Figure S7A) and from larger
tissue samples of the same myocardium of 0.48 ± 0.02 (Montag
et al., 2017). We also determined the fraction of mutated protein
in the myectomy sample with mutation A200V. The analysis
was performed by mass spectrometry as described previously
(Becker et al., 2007) (for peptides and enzyme see Supplementary
Material) and yielded a fraction of 0.54 of A200V-β-myosin
(Figure S7), which is similar to the previously determined value of
0.49± 0.01 (Montag et al., 2017). Thus, also for mutation A200V
the mean fraction of mutated MYH7-mRNA and β-MyHC-
protein in myocardial tissue samples is essentially the same,
as found for several other β-MyHC-mutations before (Tripathi
et al., 2011).
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FIGURE 2 | Fraction of mutant MYH7-mRNA and fraction of wildtype MYH7-mRNA in individual cardiomyocytes microdissected from cryosections of myocardium.
(A) Gels of restriction digest products of 3 individual cardiomyocytes microdissected from cryo-sections of A200V-myocardium. Lysate of each cell was divided in 2
equal aliquots and analyzed in parallel; L, DNA standard ladder. Note the marked differences in band pattern among different individual cardiomyocytes (cell 1-3) while
band patterns of the two aliquots of each cell are rather similar. (B) Schematic of HpyCH4III-restriction sites: 138 bp band, from wildtype MYH7-mRNA; 108 bp band,
from mutant MYH7-mRNA; 85 bp band, from mutant and wildtype mRNA; 30 bp band, from mutant MYH7-mRNA but outside range of gels. (C) Fraction of
R723G-mRNA (dark gray bars; y-axis on the left of panel) and of wildtype-mRNA (light gray bars; y-axis on the right of panel) in 35 cardiomyocytes from left ventricular
free wall of R723G-myocardium. MYH7-mRNA varies from almost pure wildtype to pure mutant. Statistics on mean values of the two aliquots after logit transformation
(see text). (D) 13 Aliquots from cDNA of R723G-myocardium (left ventricular free wall) analyzed in parallel to test for experimental scatter. Average
MYH7-mRNA-fraction is very similar to average of individual cardiomyocytes. (E) Fraction of A200V-mRNA (dark gray bars) and of wildtype-mRNA (light gray bars) in
21 cardiomyocytes of A200V myectomy-sample. Fraction varies from ≈10 to 90%. Statistics as in (C). Dash-dot line and dashed lines, means ± 1.96 SD. Normal
distribution of individual cells and multi-aliquot data (Shapiro-Wilk test). Cell-to-cell variance in fraction of mutated MYH7-mRNA for individual cardiomyocytes
significantly larger than variance of multi-aliquot control (experimental error); for R723G, p < 0.0001; for A200V, p < 0.001 (F-test).
Independent, Stochastic On-Off Switching
of Transcription of Mutant, and Wildtype
MYH7-Alleles as Possible Cause for
Cell-to-Cell mRNA and Functional
Heterogeneity
Large variability in mRNA expression with functional
heterogeneity among genetically identical cells was previously
proposed to be the result of burst-like, stochastic transcription
(Raj et al., 2006).
To test if this proposed mechanism of transcription also
applies to MYH7 and transcription of MYH7 is indeed
discontinuous, interrupted and burst-like, we visualized active
transcription sites in the nuclei of cardiomyocytes. For this
we used fluorescence in situ hybridization of cryosections of
R723G-cardiac tissue samples with two fluorescently labeled
20-mer oligonucleotide probe sets. In active transcription
sites within nuclei pre-mRNA contains both intronic and
exonic sequences. One of the two probe sets was designed
to hybridize with 48 intronic sequences of the MYH7-pre-
mRNA. The other probe set targeted 48 exonic sequences
thus labeling both MYH7-pre-mRNA as well as MYH7-mRNA.
Active transcription sites were identified as bright spots inside
the nuclei of cardiomyocytes showing co-localization of both
probe sets (Figure 3A). Cardiomyocytes were identified by
the abundant presence of cytoplasmic spots of the exonic
probe set indicating presence of MYH7-mRNA molecules. We
counted active transcription sites in 122 nuclei of cardiomyocytes
in R723G 16 µm-cryosections (13 cryosections; two R723G
cardiac tissue samples) by analyzing 3D-stacks recorded by
epifluorescence microscopy (Figure 3A) (Bahar Halpern et al.,
2015). Of these 122 nuclei 27% had no active transcription sites
but cytoplasmic MYH7-mRNA. Only nuclei fully embedded in
the tissue sections were included in the analysis. In a control
sample (5 cryosections) of a non-transplanted heart we found
32% of 240 nuclei in cardiomyocytes without active transcription
sites. Absence of active transcription sites is inconsistent with
continuous transcription of the twoMYH7-alleles but is expected
for discontinuous, stochastic, burst-like transcription.
This finding is supported by the distribution of the MYH7-
mRNA copy number in individual cells (Figure 3B,C). We
quantified the total copy number of MYH7-mRNA in 31
individual cardiomyocytes microdissected from cryosections
of R723G cardiac tissue, thereby finding copy numbers per
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cardiomyocyte-slice from <10 up to 4.660. Figures 3B,C show
this distribution on a linear and log scale. The distribution on
the log scale is consistent with a normal distribution (Shapiro-
Wilk test); the solid line represents a Gaussian fit to the decimal
logarithm of the MYH7-mRNA copy number per cell. This log-
normal distribution suggests a stochastic, burst-like transcription
mechanism (Raj et al., 2006; Raj and van Oudenaarden, 2008;
Bahar Halpern et al., 2015), while continuous transcription of the
alleles is expected to generate a Poisson-distribution on the linear
scale which is not consistent with our data (Figure 3C). Since
here slices were 5µm thick, not the full cell volume was included
in the analysis. From the average diameter of a cardiomyocyte
(16.9± 1.3µm; Olivetti et al., 1996) the mRNA-copy number per
cell should be about 3-times larger than determined in the slices.
Numerical Model Simulation of Cell-to-Cell
Variation of Mutant mRNA, Mutant Protein,
and Functional Variability Based on
Stochastic On/Off Switching of
Transcription Sites
Next we asked whether our experimental observations could
be accounted for by stochastic, burst-like transcription of the
MYH7-alleles, which is independent for the mutant and wildtype
allele. These experimental observations include the large cell-to-
cell variation in fraction of mutant vs. wildtype MYH7-mRNA
(Figure 2), the cell-to-cell functional imbalance (Figure 1), and
the 27% of R723G-cardiomyocyte nuclei having no active
transcription sites (Figure 3). To address the above question we
set up a numerical simulation for mutation R723G in which
the mutant and wildtype MYH7-alleles were switched on and
off stochastically and independently of each other. In addition,
production of pre-mRNA, splicing to mRNA, and mRNA decay
were also included in the model as was translation to and
decay of β-MyHC protein. For details of the simulations see
Supplementary Material. The rate constants for synthesis of pre-
mRNA, for degradation of mRNA, as well as for synthesis and
degradation of protein were all taken from the literature, and are
listed together with the respective references in Table S3. The only
parameters we could use to fit the response of our simulations to
the experimentally observed data were the rate constants for the
stochastic switching on and off of transcription of the two alleles,
and the rate constant of splicing of pre-mRNA to mRNA that
were not available from the literature. These three parameters
were adjusted to produce the best fit to all our above stated
experimental findings.
Since a substantial fraction of cardiomyocytes can be
polyploid, particularly in hypertrophied myocardium (Brodsky
et al., 1994), we determined the ploidy of the R723G
cardiomyocytes and included the observed distribution of di-,
tetra-, octo- 16-, and 32-ploid nuclei in our simulation (for details
see Supplementary Material).
A sample time course obtained from the model simulation of
the transcription bursts, the mutant and wildtype MYH7-pre-
mRNA, the mutant and wildtype MYH7-mRNA, the fraction
of mutant MYH7-mRNA, and the fraction of mutant protein
are shown for mutation R723G in Figure S8 for a diploid and
tetraploid cardiomyocyte. To account for a tissue-wide average
fraction of around 0.67 for both R723G MYH7-mRNA and
R723G β-MyHC (Tripathi et al., 2011; Figure S7), we adjusted
the mRNA decay rate of the R723GMYH7-mRNA to half of that
of wildtypeMYH7-mRNA.
To be able to directly compare the results of 35 individual
cardiomyocytes flash frozen and microdissected from
myocardial tissue to the outcome of the simulation (fractions
of mutant MYH7-mRNA and mutant β-MyHC protein), we
randomly picked 35 points of a very long simulation run
(see Supplementary Material). A large separation between the
randomly picked points was used to assure 35 uncorrelated,
independent points, just like in individual cardiomyocytes at
the time of freezing of the myocardial tissue. Comparing the
frequency distribution of the observed fractions of mutant
mRNA in our experimentally analyzed cardiomyocytes
(Figure 4A) with the outcome of our model (Figure 4B)
shows that the distributions are very similar. Likewise, the
values for the total number of MYH7-mRNA molecules and
their frequency distribution obtained from the simulation
at the randomly picked 35 points (Figure 4C) are similar to
the experimental data (cf. Figure 3C). Thereby we have to
consider that in 5µm cell slices the mRNA copy number is only
about 1/3 of that in whole cells with a mean diameter about
16–17µm (Olivetti et al., 1996). Also, the predicted fractions of
mutant mRNA from the 35 randomly picked points (Figure 4D)
match the experimentally determined values for individual
cardiomyocytes (cf. Figure 2C).
We next aimed to predict the fraction of mutant β-MyHC-
protein per individual cell and its effect on β-MyHC function.
Intriguingly, our model predicts that at the 35 randomly picked
points the value for the fraction of mutant β-MyHC-protein
ranges from 0.25 to 0.87, thus suggesting a marked variation
from cell to cell (Figure 4E). This is in accordance with our
hypothesis that different fractions of mutant β-MyHC may
cause the observed functional differences among individual
cardiomyocytes. We finally used the predicted fractions of
mutant protein to calculate the expected shift in pCa50 for each
cell (Figure 4F, for calculation see Supplementary Material).
Note, the mean value of the predicted pCa50 is essentially
identical with the experimentally determined one (Figure 1C).
However, the range in which 95% of all data points are expected
is somewhat narrower in the model than seen experimentally
(dashed lines in Figure 4F vs. dashed lines in Figure 1C). This
is because in the modeling only intrinsic variance of the pCa50
arising from different expression of mutant β-MyHC-protein
among individual R723G-sample cardiomyocytes is considered.
If experimental error (represented by the variance in pCa50 of
control cardiomyocytes, cf. Figure 1C, lower panel) is also taken
into account, this results in a 95% range that is very similar to
the one in the experimental data (dotted lines in Figure 4F and
dashed lines in Figure 1C).
Finally, with the best fit to all our experimental results a
fraction of 24% nuclei without active transcription sites was
predicted, which is close to the 27% seen experimentally. This
fraction is strongly dependent on the two rate constants for the
on/off-switching of the mutant and wildtype MYH7-alleles, and
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FIGURE 3 | Cardiomyocyte nuclei with 0, 1, and 2 active transcription sites, and distribution of total MYH7-mRNA copy number in 31 individual cardiomyocytes. (A)
Fluorescence in situ hybridization (FISH) to visualize active transcription sites (aTS) in 16µm thick sections of R723G cardiac tissue samples. Arrows pointing at active
transcription sites with co-localization of intronic pre-mRNA signal (red) and exonic mRNA signal (orange). Orange spots in the cytoplasm indicate individual
MYH7-mRNA molecules (exonic sequence only), identifying cells as cardiomyocytes. Shown is an example of a nucleus without aTS (upper row), a nucleus with one
aTS (2nd row; arrow head indicates non-specific fluorescent spot visible in all channels), and a nucleus with two aTS (3rd and 4th row). Note that the two aTS are
located at somewhat different z-levels, as indicated by the two slices of the z-stack shown here. In this analysis, we included only nuclei that were fully embedded in
the tissue sections. DAPI (nuclear stain) in blue; test for non-specific fluorescence signals in green (clearly visible in leftmost images only, except bright spot of
non-specific fluorescence labeled by arrow head in 2nd row). Scale bar, 5µm. (B,C) Total MYH7-mRNA copy numbers of 31 cardiomyocytes microdissected from
sections (thickness 5µm) of R723G cardiac tissue were quantified. Note that the distribution on a linear scale in (B) is not a normal distribution. Distribution of log10 of
total MYH7-mRNA copy number in (C) can well be fit by a normal distribution (solid line), which is characteristic for burst-like transcription (Raj and van Oudenaarden,
2009).
is just slightly modulated by the splicing rate constant from pre-
mRNA to mRNA. The on-times of mutant and wildtype MYH7-
alleles generate “spikes” of pre-mRNA. These are substantially
shorter than the spikes of mRNA which are longer due to the
slower mRNA decay rate. Similarly, lifetime of the β-MyHC
protein is substantially longer than of MYH7-mRNA, resulting
in smaller fluctuations of the fraction of mutant β-MyHC protein
than of mutantMYH7-mRNA (Figure S8).
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FIGURE 4 | Predictions of independent, stochastic, burst-like transcription of mutant and wildtype MYH7-alleles. Histograms (frequency distributions) of (A) observed
fraction of mutant MYH7-mRNA in the 35 microdissected R723G cardiomyocytes (cf. Figure 2C) and of (B) fraction of mutant MYH7-mRNA at 35 randomly picked
points of a very long model simulation of transcription with independent, stochastic on/off switching of mutant and wildtype alleles. (C) Log-normal distribution of total
copy number of MYH7-mRNA obtained from the model simulation at the 35 points, simulating cardiomyocytes microdissected from 5µm thick cryo-sections.
Simulated numbers were divided by 3 to account for 5µm thickness of patient’s tissue sections that represents only about 1/3 of full cardiomyocyte volume.
Distribution slightly narrower than for experimental quantification (cf. Figure 3C). (D) Predicted fraction of mutant and wildtype MYH7-mRNA (cf. Figure 2C) and (E)
predicted fraction of mutant and wildtype β-MyHC (protein) at the 35 randomly picked points; dash-dot line and dashed lines, means ±1.96 SD. In (D,E) dark gray
bars indicate fraction of mutant MYH7-mRNA (D) and mutant protein (E) (y-axis on the left), and light gray areas indicate fraction of wildtype MYH7-mRNA (D) and
wildtype protein (E) (y-axis on the right). (F) Predicted distribution of pCa50-values (filled circles) as expected from an experimentally determined mean fraction of
mutant β-MyHC-protein of 0.67 (Tripathi et al., 2011) that shifts pCa50 by 0.15 pCa-units to the right (Figure S5A) without taking experimental error into account
(dash-dot lines, mean; dashed lines, ±1.96 SD). Dotted lines, 95% range when taking experimental error into account (for details see Supplementary Material). Note
the very similar 95% range as in Figure 1C for R723G cardiomyocytes.
DISCUSSION
In this study, we tested the hypothesis that a functional
heterogeneity exists among individual cardiomyocytes in
myocardium of HCM patients that results from cell-to-cell
variation in the fraction of mutant β-MyHC. Functional
heterogeneity with imbalance in force generation during
twitches among neighboring cardiomyocytes may well contribute
to development of disarray, hypertrophy and fibrosis in HCM in
the long run.
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The main findings of our present study are (i) a quite
substantial heterogeneity in Ca++-sensitivity among individual
cardiomyocytes with two different HCM related β-MyHC-
mutations, mutation R723G and mutation A200V, respectively
(Figure 1), (ii) large cell-to-cell variation in the fraction
of mutant MYH7-mRNA among individual cardiomyocytes
isolated from the same tissue samples (Figure 2), and (iii)
absence of active transcription sites in 27% of nuclei in R723G
cardiomyocytes indicating discontinuous, stochastic, burst-like
transcription of the two MYH7-alleles (Figure 3). (iv) To test
for an underlying mechanism that may provide a link between
the experimental findings, numerical simulations were set up.
They suggest that stochastic on/off switching of transcription
of MYH7, which is independent for the mutant and the
wildtype allele, can result in the observed cell-to-cell variation in
mutant MYH7-mRNA and protein. Since the mutation reduces
calcium-sensitivity, the variation in mutant myosin may also
cause highly heterogeneous Ca++-sensitivity among individual
cardiomyocytes (Figure 4). Thus, independent, stochastic on/off
switching of transcription could reproduce the experimentally
observed significant functional imbalance among individual
cardiomyocytes isolated from the same piece of myocardial
tissue as well as the observed fraction of nuclei without active
transcription sites.
Our data and modeling suggest that the observed cell-to-cell
variability in the fraction of mutated and wildtypeMYH7-mRNA
corresponds to a similar variability in the fraction of mutated
and wildtype β-MyHC at the protein level, although the extent
of this variability is smoothened by the lifetime of the protein (cf.
Figure S8). Thus, since the observed fraction of MYH7-mRNA
ranged from near zero (0.05) to essentially pure (1.0) mutant
mRNA, the predicted protein fractions will presumably range
from about 0.25 to 0.90, which represents a remarkable difference
between the individual cells. Although protein quantification was
not possible for individual cardiomyocytes, already the functional
data corroborate this prediction. The calcium sensitivity of some
cardiomyocytes was indistinguishable from controls (Figure 1).
This suggests that these cardiomyocytes had little mutant myosin
but mostly wildtype myosin in their sarcomeres at the time of
freezing of the sample. On the other hand, cardiomyocytes with
the largest shift of the force-pCa-curve most likely contained
quite a large fraction of mutant myosin.
The correspondence of the mean fraction of mutated protein
to the mean fraction of mutated MYH7-mRNA is further
supported by our previous work on tissues of several HCM
patients with β-MyHC-mutations including cardiac samples
with mutation R723G (Tripathi et al., 2011), and by protein
quantification of tissue samples withmutation A200V (Figure S7)
(Montag et al., 2017). In all cases a close correlation between the
mean fractions of mutantMYH7-mRNA andmutant protein was
found.
Importantly, the populations of individual cardiomyocytes
from which we determined the fraction of mutant MYH7-
mRNA are representative for the cardiomyocyte populations in
larger tissue samples. This is evident from the average fractions
of mutant MYH7-mRNA of the individual cardiomyocytes,
0.70 for R723G mutation and 0.53 for A200V cardiomyocytes
(Figures 2C,E), which are very close to the fractions determined
in larger tissue samples, 0.70 for R723G and 0.47 for A200V
(Figure S7) (Montag et al., 2017).
Possible Mechanism for Cell-to-Cell
Variation in Mutant MYH7-mRNA and
β-MyHC-Protein
Continuous expression of both alleles could only account for the
observed large variation in the fraction of mutantMYH7-mRNA
among individual cardiomyocytes if only a low copy number
(<50) of the MYH7-mRNA was generated per cardiomyocyte
(Raj and van Oudenaarden, 2009). Also, continuous expression
is expected to generate a Poisson distribution of the mRNA copy
number per cell (Raj and van Oudenaarden, 2009). Both points,
however, are inconsistent with our data. Absolute quantification
revealed a log-normal distribution with a mean of 416 MYH7-
mRNA molecules per cell in the 5µm tissue sections (Figure 3),
yielding an expected median of about 1,200 mRNAmolecules per
cell.
Another possibility to account for the large cell-to-cell
variation in mutant/wildtype MYH7-mRNA is random,
monoallelic expression of the MYH7-gene. In fact, for fractions
of mutant MYH7-mRNA ≥ 0.9 and ≤ 0.1 we cannot rule
out that the small amount of wildtype or mutant mRNA,
respectively, results from cross-contamination in cryosectioning
and microdissection. That a large number of cardiomyocytes,
however, have fractions of mutant MYH7-mRNA between
0.1 and 0.9 makes monoallelic expression rather unlikely. In
addition, we also determined cells with more than one active
transcription site, which seems incompatible with monoallelic
expression. The functional data also argue against monoallelic
expression as we do not see two clearly separate groups of
force-pCa relations, one like controls, the other clustering
around a lower pCa50 value. We rather see a continuum of
curves (Figure 1).
Therefore, the mechanism responsible for the large variance
in the fraction of mutant MYH7-mRNA should account for
both, cardiomyocytes with mixed mutant and wild-type MYH7-
mRNA expression, and for essentially monoallelic expression.
Using model simulations we show that stochastic, burst-like
transcription of the mutant, and wildtype MYH7 alleles, due to
stochastic opening and closing of chromatin (Janicki et al., 2004),
can account for our experimental data. Burst-like transcription
has been described in eukaryotic (Chubb et al., 2006) and
mammalian cells (Raj et al., 2006), as well as in intact mammalian
tissue (Raj et al., 2006; Bahar Halpern et al., 2015). This
mechanism has been proposed as the basis for large cell-to-
cell variation in the number of specific protein molecules in
genetically identical cells. In these earlier studies, however, no
distinction was made between transcription of the two alleles of a
particular gene like mutant and wildtype as done in our study.
Yet, because of the heterozygous genotype, we can
distinguish between mutant and wildtype alleles and clearly
see heterogeneous expression of the two alleles among
cardiomyocytes. Therefore, we set up a numerical model based
on the concept of burst-like transcription, which is independent
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for the two alleles, mutant and wildtype. This modeling revealed
a surprisingly close match with our experimental data, including
cell-to-cell variation in mutant MYH7-mRNA and in pCa50,
as well as the distribution of the total MYH7-mRNA copy
number among individual cardiomyocytes (Figure 4; Figure S8).
Interestingly, with stochastic, burst-like transcription of mutant
and wildtype alleles, a cardiomyocyte is expected to change at
the mRNA- and protein-level, once in a while, from an almost
wildtype cell via a mixed cell to a cell expressing almost pure
mutant protein, and vice versa (cf. Figure S8).
How Could Cell-to-Cell Functional
Imbalance Affect Myocardial Function and
Contribute to HCM Development?
The mutations studied here, like most HCM mutations,
alter force generation and Ca++-sensitivity of the sarcomere,
consistent with the “poison peptide” mechanism (Ashrafian
et al., 2011). Therefore, it seems likely that sarcomeres with
high or low amounts of mutant β-MyHC generate different
force levels during each twitch/heartbeat, as suggested by
the heterogeneity in force generation at partial activation
(Figure 1). Cardiomyocytes with low force would get distorted
and stronger cardiomyocytes may over-contract. According to
our model calculations, this will change with the expression of
mutant β-MyHC over time (Figure S8), affecting neighboring
cardiomyocytes randomly (Brenner et al., 2014). Since the
myocardium is a network, where adjacent strands of serially
arranged cardiomyocytes are interconnected by branched
cardiomyocytes, such a functional mosaic may well contribute
to the severe myocyte disarray typical for HCM (Varnava
et al., 2000). Therapeutic reduction in force generation, e.g.,
by β-adrenergic blockers or calcium antagonists, results in a
milder phenotype, as may specific small molecule inhibitors of
cardiomyocyte force generation, since functional imbalance and
cellular distortions will be smaller. Along these lines, diltiazem
treatment of pre-clinical HCM mutation carriers suggested a
delay in early left ventricular remodeling (Ho et al., 2015b).
Even myofibrillar disarray within individual cardiomyocytes
may develop since myofibrils, dependent on the time of their
formation, may have quite different abundance of the mutant
protein, generating subcellular functional imbalance among
individual myofibrils. Electron microscopy revealed extensive
disarray and loss of myofibrils in myocardium of the affected
HCM patients in this (Figure 5) and previous studies (Ferrans
et al., 1972; Kraft et al., 2013; Witjas-Paalberends et al., 2013).
This is consistent with more disordered sarcomere structure of
mutated cardiomyocytes in light micrographs (Figures 5A,B)
and the observed reduced force generation per cross-sectional
area of cardiomyocytes of affected patients compared to controls
(Figure S5).
It should be noted that the observed heterogeneity among
individual cardiomyocytes will most likely not be the only trigger
of HCM-development. The globally increased or decreased
myofilament calcium sensitivity caused by the mutations may
well lead directly to remodeling and alterations of whole heart
function, while cell-to-cell heterogeneity could exacerbate the
phenotype. This is supported by findings in a severely affected
homozygous HCM-patient, who developed cardiomyocyte
hypertrophy and abnormal myofibrillar orientation (Nishi et al.,
1994). Yet, it cannot be ruled out that an undetected additional
compound heterozygous mutation may have contributed to
this patient’s phenotype. Overall, homozygous patients are very
rare but they often show a severe and early onset phenotype
that differs from that of heterozygous patients (Nishi et al.,
1994; Richard et al., 2003). Similarly, homozygous mice with
α-myosin- mutation Arg403Gln die within 7 days after birth,
while the heterozygous animals apparently have normal life span
where they develop several of the major characteristics of human
HCM, including myocyte disarray (Geisterfer-Lowrance et al.,
1996).
Importantly, our contractile imbalance hypothesis and the
poison peptide principle do not exclude each other. Instead, the
functional alterations caused by the mutated β-MyHC which
is incorporated into the sarcomeres (poison peptide effect) are
an essential starting point for development of the contractile
imbalance. We suggest, based on our data that the fractions
of functionally different mutated and wildtype β-MyHC in the
sarcomeres vary from cell-to-cell due to stochastic burst-like
expression of the two alleles. The resulting cell-to-cell contractile
imbalance may particularly enhance progressive development
of specific HCM features like structural distortions leading to
cellular andmyofibrillar disarray and interstitial fibrosis (Brenner
et al., 2014).
LIMITATIONS OF THE STUDY
One limitation of the work presented here is that fractions of
mutant vs. wildtype mRNA and contractile function cannot be
studied on the same cardiomyocytes, thus precluding a direct
causal relation between cell-to-cell contractile imbalance, burst-
like transcription, and variation in expression of mutated β-
MyHC among individual cardiomyocytes. Our functional studies
require chemically permeabilized cardiomyocytes where the
cytoplasm is replaced by physiological solutions with defined
calcium concentrations. This precludes subsequent mRNA-
isolation and analysis so that we have to rely on data from two
groups of cardiomyocytes which, however, were isolated from the
same pieces of cardiac tissue. In addition, the fractions of mutant
vs. wildtype myosin protein cannot be studied at the single
cell level since this requires a quantitative mass spectrometry
approachwith single cell sensitivity which is not available. Instead
we suggest that the large functional variability (e.g., of pCa
curves) of the cardiomyocytes is an indirect measure for cell-to-
cell variability of mutated protein in the sarcomeres.
We also cannot exclude that post-translational modifications
of contractile proteins which may even vary from cell-to-
cell contribute to the observed decrease in Ca++-sensitivity
and the functional heterogeneity among individual mutated
cardiomyocytes. However, the increased heterogeneity in HCM-
patients as compared to donors was detected even though at
least PKA-dependent phosphorylation levels were adjusted for all
cardiomyocytes by treatment with PKA.
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FIGURE 5 | Micrographs of mounted cardiomyocytes and EM images of control and R723G samples. (A) Control cardiomyocytes from donor myocardium.
(B) Cardiomyocytes with mutation R723G. Note that cardiomyocytes with mutation R723G have less well organized striation patterns than controls, consistent with
myofibrillar disarray previously described for cardiomyocytes from affected HCM-patients (Kraft et al., 2013). (C,D) Electron micrographs of myocardial tissue from
control (C) and patient with mutation R723G (D). Different from control tissue, EM images of R723G tissue show longitudinally (l), obliquely (o), and cross sectioned (c)
myofibrils right next to each other within individual cell (d, right panel) as indication of myofibrillar disarray. Z-disks (Z), M-lines (M), mitochondria (Mi), T-tubuli (T), a
nucleus (Nu), and lipofuscin granula (Li) are indicated.
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The data presented here from three HCM-patients provide
experimental evidence for highly variable expression of β-
MyHC-mutations in two male patients at end stage of the disease
(R723G) and in a female patient (A200V) undergoing myectomy
at the age of 19 years (see Supplementary Material). Despite
the limitation to three patients the data indicate, however, that
the variable allelic expression from cell-to-cell is not associated
with the end stage situation of the HCM-heart. Yet, whether
the proposed concept of independent, stochastic, burst-like
transcription of the two alleles as trigger for HCMdoes also apply
toMYH7-mutations that cause an increase in calcium-sensitivity
and to HCM-mutations in other sarcomeric proteins remains to
be elucidated in further studies.
CONCLUSION
Our data show a significant cell-to-cell variation in mutated
vs. wildtypeMYH7-mRNA-expression and contractile properties
among individual cardiomyocytes isolated from the same
tissue samples of HCM patients with two different β-MyHC-
mutations. This large variability at the mRNA-level is most
likely due to stochastic, burst-like MYH7-transcription, which is
independent for the mutant and the wildtype allele, leading to
a similarly large cell-to-cell variability in mutated vs. wildtype
protein. The resulting large variation in contractile properties
among individual cardiomyocytes may contribute to cellular and
myofibrillar disarray and, by distortion of non-cardiomyocytes,
trigger stretch sensitive signaling paths that lead to development
of interstitial fibrosis. We hypothesize that such stochastic, burst-
like transcription of the related alleles may also induce similar
changes for other heterozygous HCMmutations.
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